DTC marketers disconnect from digital marketing

World of DTC Marketing

You need to invest in digital marketing too. DTC marketers should be joined at the hip with their market research people. What I have found is that too many DTC marketers make mistakes by applying generic research to their product categories. When launching a new drug you should be getting weekly reach and awareness reports from your market research people. Marketing is not science; it’s an art.

Pharma: The time is now for digital marketing

World of DTC Marketing

SUMMARY : Digital marketing is not a tactic. This will carry over to DTC marketing as well but simply adding more money is not going to equal success. To master digital marketing, pharma needs to be prepared to fail. Digital not only applies to DTC but to HCP marketing as well.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ten pharma digital marketing facts

World of DTC Marketing

5ive: The biggest obstacle, I have observed, to innovative pharma digital marketing is the lack of talent. They should be integrated fully with the brand especially when it comes to market research findings. As I See It Bad Pharma Digital marketing

Prescription drug marketing misconceptions

World of DTC Marketing

Another TED talk on the evils of prescription drug marketing was filled with misinformation as usual. The disconnect between consumers and prescription drug marketing has grown quite a bit. What about marketing to doctors?

Pharma’s move to digital Part 2 DTC Marketing

World of DTC Marketing

OPENING : DTC marketers have relied too much on TV advertising. DTC marketers have relied too heavily on TV, and now new data shows that TV glory days are quickly fading and that people feel that commercials are repeated too frequently and are irrelevant to them.

DTC Marketers job just got harder

World of DTC Marketing

” While the sample is too small to make any immediate judgments it should be worrying to DTC marketers. Before COVID-19, the United States telehealth market was estimated at about $3 billion with 11% of consumers using telehealth in 2019.

Pharma’s move to digital Part 1 HCP Marketing

World of DTC Marketing

OPENING: Pharma companies are starting to embrace digital marketing forced, in large part, by changes brought on by the pandemic. Digital marketing is becoming a valuable tool. The post Pharma’s move to digital Part 1 HCP Marketing appeared first on World of DTC Marketing.com.

As pharma abandons the antibiotic market patients are at risk

World of DTC Marketing

A pull strategy is needed with financial incentives to repair the broken market for antibiotics and make it worthwhile for the pharma industry to bring promising drugs to market.

Thrombocytopenia Drugs Market: What Newer Agents Are Expected To Enter The Market?

Delveinsight

The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market.

The role of optimized omnichannel marketing in a challenging environment

Bio Pharma Dive

How can pharma marketers overcome today's cost-constrained, competitive environment

Achieving success in pharma marketing: The need for a personalized, omnichannel approach

Bio Pharma Dive

Personalized, insight-driven omnichannel marketing has never been more beneficial or important

Personalize your omnichannel marketing today and see the benefits tomorrow

Bio Pharma Dive

With virtual interactions here to stay, it's important that pharma marketers continue to embrace the digital world. Learn how a personalized, insights-led approach to marketing drives results

4 principles for the future of pharma marketing

Pharma Phorum

COVID-19 has disrupted markets and accelerated digital adoption but what does this mean for the future of marketing? In this feature, Grünenthal’s Florent Eduoard and Kate Hurtig outline their principles for a new pharmaceutical marketing model. .

The US biosimilar market: Predictions for 2021

Pharma Phorum

It has been five years since the first biosimilar launched in United States market—marking the first steps in expanding access to innovative biologic-based treatments that help patients manage and treat difficult illnesses such as cancer, rheumatoid arthritis, and other life-altering diseases.

2021 market access prospects for Germany

Pharma Phorum

The market access landscape in Germany is particularly interesting in 2021, as a key component – AMNOG – is ten years old, and that milestone prompts reflections on what has worked well and what needs reform. In 2021 we might see the ripples from such policies come into the market.

10 things DTC marketers should focus on in 2021

World of DTC Marketing

KEY TAKEAWAY: Consumer behavior has changed due to the pandemic, and DTC marketers should be aware of how consumers will evaluate and choose prescription drugs. DTC marketers need to be ready to understand and help patients who request new medications via telehealth or email.

How pharma digital marketing can excel

World of DTC Marketing

Pharma digital marketing has been lagging behind key trends for a long while. Let’s face it, pharma organizations are not made for speed while digital marketing is all about “now” Digital marketing is also about experimentation and learning from successes as well as failures.

2021 market access prospects for France

Pharma Phorum

In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring for market access in France. That could signal a greater willingness to find solutions that can aid market access faced with cutting edge treatments.

2021 market access prospects for Spain

Pharma Phorum

2021 will be the year when big market access changes – including the far wider use of health economic evaluation – are implemented in Spain. Proof will be in the pudding but health economics is primed to play a far bigger role in market access in 2021 in Spain.

2021 – UK market access prospects

Pharma Phorum

With a new year comes the opportunity to think ahead for the market access landscape for the coming year. 2020 was a big year for market access initiatives in the UK, many of which are only just starting, and their impact will come through in 2021 and beyond.

AstraZeneca betting on China’s PD-1 cancer market

BioPharma Reporter

AstraZeneca has signed a deal with Chinese biotech, Junshi Biosciences, to market its cancer immunotherapy. Markets & Regulations

Allocating Your B2B Marketing Budget In 2021

XTalks

B2B marketers are preparing themselves for what lies ahead in 2021 after the fallout from the COVID-19 pandemic. . The widespread economic shutdown created a negative return on investment for marketers during the previous year. The Marketing Budget Plan. Email marketing .

Emerging Research Continues To Transform Erythropoietic Protoporphyria Market Outlook

Delveinsight

Hematopoietic stem cell transplantation is a curative option in the EPP treatment market, however, is not routinely done owing to safety concerns. Bone marrow transplantation has helped improve patient outcomes, however, the Erythropoietic protoporphyria market lacks a curative option. .

COVID-19 and the digital pharma marketing revolution

Pharma Phorum

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. With medical staff working tirelessly and lockdown restrictions in place across the world, the way pharma markets medications has changed, too.

Hypofibrinogenemia Market: Limited Pipeline Therapies, Abundant Opportunities

Delveinsight

The Hypofibrinogenemia market requires curative treatment options, new diagnostics methodologies for easier identification of high-risk patients, and safer, standard, and effective replacement therapy. Articles Hypofibrinogenemia Hypofibrinogenemia Market rare blood diseases Rare Disease

United States Lung Cancer Market 2021: Pipeline Products, Market Analysis, Epidemiology, Key Products Marketed, Drugs Sales and Market Shares – ResearchAndMarkets.com

BioTech 365

United States Lung Cancer Market 2021: Pipeline Products, Market Analysis, Epidemiology, Key Products Marketed, Drugs Sales and Market Shares – ResearchAndMarkets.com United States Lung Cancer Market 2021: Pipeline Products, Market Analysis, Epidemiology, Key Products Marketed, Drugs Sales and Market Shares … Continue reading → Business Wire

Sales 40

Global Immunohematology Market Research 2020-2024 | Market Planning Structure | Technavio

BioTech 365

Global Immunohematology Market Research 2020-2024 | Market Planning Structure | Technavio Global Immunohematology Market Research 2020-2024 | Market Planning Structure | Technavio LONDON–(BUSINESS WIRE)–#GlobalImmunohematologyMarket–The immunohematology market is poised to grow by USD 846.80

Antibody-Mediated Rejection Market Insight, Epidemiology and Market Forecast Report 2021-2030 – ResearchAndMarkets.com

BioTech 365

Antibody-Mediated Rejection Market Insight, Epidemiology and Market Forecast Report 2021-2030 – ResearchAndMarkets.com Antibody-Mediated Rejection Market Insight, Epidemiology and Market Forecast Report 2021-2030 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Antibody-Mediated Rejection – Market Insight, Epidemiology and Market Forecast 2030” drug pipelines has been … Continue reading → Business Wire

Drugs 40

Global Aromatherapy Market to Surpass US$ 8,763.3 Million by 2027, Says Coherent Market Insights (CMI)

BioTech 365

Global Aromatherapy Market to Surpass US$ 8,763.3 Million by 2027, Says Coherent Market Insights (CMI) Global Aromatherapy Market to Surpass US$ 8,763.3

China In-Vitro Diagnostics Market Report 2020-2024: Market is Poised to Grow by $6.93 Billion – ResearchAndMarkets.com

BioTech 365

China In-Vitro Diagnostics Market Report 2020-2024: Market is Poised to Grow by $6.93 Billion – ResearchAndMarkets.com China In-Vitro Diagnostics Market Report 2020-2024: Market is Poised to Grow by $6.93 Billion – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “China In-Vitro Diagnostics Market 2020-2024” report … Continue reading → Business Wire

Cystic Fibrosis Market: A Rapidly Expanding Playing Field for Mid-Cap Pharma

Delveinsight

Analysts at DelveInsight expect major changes in the Cystic Fibrosis market landscape in the foreseeable future. Some of the highlights from the ongoing transformation of the current market dynamics are as follows: Rapidly Growing Eligible Patient Pool. Promising Market Outlook.

RNA 52

Orthocell Receives US Market Clearance

BioTech 365

Global Pyrazinamide Market to Surpass US$ 163.1 Mn by 2027, Says Coherent Market Insights (CMI)

BioTech 365

Global Pyrazinamide Market to Surpass US$ 163.1 Mn by 2027, Says Coherent Market Insights (CMI) Global Pyrazinamide Market to Surpass US$ 163.1

Rheumatoid Arthritis: Causes, Risk Factors, Treatment Approaches and Market Landscape

Delveinsight

As of now, there is no cure for Rheumatoid Arthritis; however, medication and supportive treatments options are available in the market that can manage its progression. As per the Delveinsight, the total prevalent cases of Rheumatoid Arthritis in the seven major markets (i.e

2021 market access prospects for Italy

Pharma Phorum

Italy was working up big changes in market access throughout 2020 which will be implemented in 2021. In the latest of a suite of features looking at the biggest markets in Europe, Leela Barham takes stock of what 2021 could bring for market access in Italy.

Global perspectives on consumer-centric marketing

The Pharma Data

SGK Health’s digital marketing experts provide insights that can help build deeper, emotional connections with pharma consumers to amplify digital marketing strategies as marketers shift their focus toward consumer-centric marketing.

Global Ambulatory Infusion Center Market to Surpass US$ 51,244.7 Million by end of 2027, Says Coherent Market Insights (CMI)

BioTech 365

Global Ambulatory Infusion Center Market to Surpass US$ 51,244.7 Million by end of 2027, Says Coherent Market Insights (CMI) Global Ambulatory Infusion Center Market to Surpass US$ 51,244.7

Market Survey by TSUNO Group Reveals “Rice Bran Oil” Market in Japan Is Expanding Under COVID-19 Pandemic

BioTech 365

Market Survey by TSUNO Group Reveals “Rice Bran Oil” Market in Japan Is Expanding Under COVID-19 Pandemic Market Survey by TSUNO Group Reveals “Rice Bran Oil” Market in Japan Is Expanding Under COVID-19 Pandemic In Japan the “Rice Bran Oil” … Continue reading → Business Wire

The Now and the Next: Advice for Pharma Marketers in the New Normal

Intouch Solutions

The post The Now and the Next: Advice for Pharma Marketers in the New Normal appeared first on Intouch Solutions. Blog Healthcare Marketing HCP Marketing Innovation Strategic Planning

Guest Episode – DarshanTalks: Marketing and Evolving Patient Centricity – February 1, 2021

Pharma Marketing Network

The Pharma Marketing Podcast is pleased to present this special guest episode from our friend and Editorial Advisory Board member Darshan Kulkarni, Marketing and Evolving Patient Centricity – January 27, 2021. Featured Pharma Marketing Podcasts

PsyBio Therapeutics Announces Retention of Market Maker

BioTech 365

PsyBio Therapeutics Announces Retention of Market Maker PsyBio Therapeutics Announces Retention of Market Maker TORONTO, March 04, 2021 (GLOBE NEWSWIRE) — PsyBio Therapeutics Corp. TSXV:PSYB) (“PsyBio” or the “Company”), a leader in the field of psychedelic research and drug development, announces that, subject to the receipt … Continue reading → GlobeNewswire

Drugs 40

Global Pharmaceutical Contract Packaging Market Research 2020-2024 | COVID-19 Market Impact Analysis | Technavio

BioTech 365

Chronic Refractory Cough Market and the Monopoly of the Over-The-Counter Drugs

Delveinsight

However, the Chronic refractory cough market is dominated by off-label therapies. However, DelveInsight’s Chronic refractory cough market is majorly dominated by nonpharmacologic therapies, which include Speech Therapy and Physiotherapy. Cough! Cough!